Unresectable Hepatocellular Carcinoma: Meta-Analysis of Arterial Embolization [letter]
2004; Radiological Society of North America; Volume: 230; Issue: 1 Linguagem: Inglês
10.1148/radiol.2301030753
ISSN1527-1315
Autores Tópico(s)Hepatitis B Virus Studies
ResumoHomeRadiologyVol. 230, No. 1 PreviousNext Letters to the EditorUnresectable Hepatocellular Carcinoma: Meta-Analysis of Arterial Embolization [letter]Josep M. Llovet, Jordi BruixJosep M. Llovet, Jordi BruixAuthor AffiliationsBarcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit, Digestive Disease Institut, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Villaroel 170, 08036 Barcelona, Spain. e-mail: [email protected]Josep M. LlovetJordi BruixPublished Online:Jan 1 2004https://doi.org/10.1148/radiol.2301030753MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References 1 Cammà C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54. Link, Google Scholar2 Myers R. Meta-analysis of transarterial embolization in patients with unresectable hepatocellular carcinoma (letter). Radiology 2003; 227:611-612. Link, Google Scholar3 Cammà C, Schepis F, Cottone M, Craxi A. Reply (letter). Radiology 2003; 227:612-613. Google Scholar4 Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27:1578-1583. Crossref, Medline, Google Scholar5 Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739. Crossref, Medline, Google Scholar6 Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171. Crossref, Medline, Google Scholar7 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37:429-442. Crossref, Medline, Google Scholar8 Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 316:61-66. Crossref, Medline, Google Scholar9 Pelletier G, Roche A, Ink O, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-184. Crossref, Medline, Google Scholar10 Okamura J, Kawai S, Ogawa M, et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison of L-TAE with Farmorubicin and L-TAE with adriamycin (second cooperative study)—The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol 1992; 31:S20-S24. Crossref, Medline, Google Scholar11 Kawata S, Yamasaki E, Nagase T, et al. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma: s randomized controlled trial. Br J Cancer 2001; 84:886-891. Crossref, Medline, Google Scholar12 Kajanti M, Pyrhonen S, Mantyla M, Rissanen P. Intra-arterial and intravenous use of 4′ epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma: a randomized comparison. Am J Clin Oncol 1992; 15:37-40. Crossref, Medline, Google Scholar13 Uchino J, Une Y, Sato Y, Gondo H, Nakajima Y, Sato N. Chemohormonal therapy of unresectable hepatocellular carcinoma. Am J Clin Oncol 1993; 16:206-209. Crossref, Medline, Google Scholar14 Madden MV, Krige JE, Bailey S, et al. Randomised trial of targeted chemotherapy with lipiodol and 5- epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1993; 34:1598-1600. Crossref, Medline, Google Scholar15 Bhattacharya S, Novell JR, Dusheiko GM, Hilson AJ, Dick R, Hobbs KE. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 1995; 76:2202-2210. Crossref, Medline, Google Scholar16 Chung YH, Song IH, Song BC, et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000; 88:1986-1991. Crossref, Medline, Google Scholar17 Lu CD, Qi YG, Peng SY. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma. Chin Med J (Engl) 1994; 107:209-215. Medline, Google ScholarArticle HistoryPublished in print: Jan 2004 FiguresReferencesRelatedDetailsCited ByTransvascular therapy of Hepatocellular Carcinoma (HCC), status and developmentsDanielGnutzmann, NikolasKortes, MigleSumkauskaite, AnneSchmitz, Karl-HeinzWeiss, BorisRadeleff30 January 2018 | Minimally Invasive Therapy & Allied Technologies, Vol. 27, No. 2Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolizationAyele H.Negussie, Matthew R.Dreher, Carmen GacchinaJohnson, YiqingTang, Andrew L.Lewis, GertStorm, Karun V.Sharma, Bradford J.Wood24 June 2015 | Journal of Materials Science: Materials in Medicine, Vol. 26, No. 6Quality assessment of clinical research on liver cancer treated by intra-arterial infusion of Chinese medicineXiao-fengZhai, Cui-xiaQiao, QunLiu, ZheChen, Chang-quanLing13 August 2013 | Chinese Journal of Integrative Medicine, Vol. 20, No. 11Long-Term Outcomes Comparing Surgery to Embolization-Ablation for Treatment of Solitary HCC <7 cmEldadElnekave, Joseph P.Erinjeri, Karen T.Brown, Raymond H.Thornton, Elena N.Petre, MajidMaybody, Mary A.Maluccio, MeierHsu, Constantinos T.Sofocleous, George I.Getrajdman, Lynn A.Brody, Stephen B.Solomon, WilliamAlago, YumanFong, William R.Jarnagin, Anne M.Covey7 April 2013 | Annals of Surgical Oncology, Vol. 20, No. 9Radiodosimetric Estimates for Radioembolic Therapy of Liver Tumors: Challenges and OpportunitiesA.Claudio Traino, GiuseppeBoni, GiulianoMariani12 March 2012 | Journal of Nuclear Medicine, Vol. 53, No. 4Heat generation ability in AC magnetic field of needle‐type Ti‐coated mild steel for ablation cancer therapyFabrizioDughiero, TakashiNaohara, HiromichiAono, HideyukiHirazawa, TsunehiroMaehara, YujiWatanabe, ShinyaMatsutomo2011Sep13 | COMPEL - The international journal for computation and mathematics in electrical and electronic engineering, Vol. 30, No. 5Extrahepatic vessels depending on the hepatic artery. Identification and managementJ.Arias Fernández, B.Martín Martín, N.Pinheiro da Silva, M.L.Díaz, J.I.Bilbao2011Jan1 | Radiología (English Edition), Vol. 53, No. 1Vasos extrahepáticos dependientes de la arteria hepática. Identificación y manejoJ.Arias Fernández, B.Martín Martín, N.Pinheiro da Silva, M.L.Díaz, J.I.Bilbao2011Jan1 | Radiología, Vol. 53, No. 1Das hepatozelluläre Karzinom aus der Sicht des Internisten und des ChirurgenH.C.Spangenberg, O.Drognitz, R.Thimme, U.Hopt25 June 2009 | Der Gastroenterologe, Vol. 4, No. 4Upper gastrointestinal tumors: current status and future perspectivesYixingJiang, Eric TKimchi, Alberto JMontero, Kevin FStaveley-O’Carroll, Jaffer AAjani10 January 2014 | Expert Review of Anticancer Therapy, Vol. 8, No. 6Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancerMagnusRizell, MatsAndersson, ChristianCahlin, LarsolofHafström, MichaelOlausson, PerLindnér29 February 2008 | International Journal of Clinical Oncology, Vol. 13, No. 1Treatment options for hepatocellular carcinomaDalbir SSandhu, Vivek STharayil, Jin-PingLai, Lewis RRoberts10 January 2014 | Expert Review of Gastroenterology & Hepatology, Vol. 2, No. 1Hepatocellular carcinoma: future perspectivesH. E.Blum, L.Lan, H. CSpangenberg2008Jan1Acute Pancreatitis after Embolization of Liver Tumors: Frequency and Associated Risk FactorsR.López-Benítez, B.A.Radeleff, H.M.Barragán-Campos, G.Noeldge, L.Grenacher, G.M.Richter, P.Sauer, M.Büchler, G.Kauffmann, P.J.Hallscheidt2007May1 | Pancreatology, Vol. 7, No. 1Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using 90Yttrium resin-microspheresTobias F.Jakobs, Ralf-T.Hoffmann, GabrielePoepperl, AnnaSchmitz, JürgenLutz, WalterKoch, KlausTatsch, AndreasLubiensky, Maximilian F.Reiser, ThomasHelmberger6 December 2006 | European Radiology, Vol. 17, No. 5Regionale Therapie von LebertumorenH.C.Spangenberg, L.Mohr, H.E.Blum2007Jan1 | Der Internist, Vol. 48, No. 1Lokal-ablative TherapieH. C.Spangenberg2007Jan1 | Der Gastroenterologe, Vol. 2, No. 1Malignant liver tumours2006Jan1Treatment of hepatocellular carcinomaHubert E.Blum2005Feb1 | Best Practice & Research Clinical Gastroenterology, Vol. 19, No. 1Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytesXin-QinKang, Wei-JinZang, Li-JunBao, Dong-LingLi, Tu-ShengSong, Xiao-LiXu, Xiao-JiangYu2005Jan1 | World Journal of Gastroenterology, Vol. 11, No. 47Recommended Articles RSNA Education Exhibits RSNA Case Collection Vol. 230, No. 1 Metrics Altmetric Score PDF download
Referência(s)